나노의학 시장(2026-2030년) : 나노 유형, 모달리티, 용도별

Overview:

Nanomedicine refers to the application of nanotechnology in medicine, specifically for the diagnosis, treatment, and prevention of diseases. It involves using nanoscale materials and devices to interact with biological systems at the molecular and cellular levels. Nanomedicine aims to improve healthcare by delivering therapeutic agents, imaging agents, or diagnostics with enhanced precision, efficiency, and targeted capabilities.

Nanotechnology enables scientists to manipulate and engineer materials at the nanoscale, typically ranging from 1 to 100 nanometers. At this scale, materials exhibit unique properties and behaviors that differ from their bulk counterparts. These properties can be harnessed to develop novel approaches for medical applications.

This Mind Commerce report investigates nanomedicine and nanomedicine-based products and services including nanoparticles used in nanomedicine. The report also analyzes market factors and challenges related to the nanomedicine market's potential application areas, products and services.

The report assesses products and services, and strategic initiatives of leading nanomedicine companies. It includes qualitative and quantitative analysis including market forecasts for 2026 through 2030.

Table of Contents

1.0 Executive Summary

2.0 Introduction

• 2.1 Defining Nanomedicine
• 2.2 Nanomedicine Market Drivers
• 2.3 Nanomedicine Market Challenges
• 2.4 Pandemic Impact Analysis
• 2.5 Nanomedicine Regulatory Analysis
• 2.6 Nanomedicine Value Chain Analysis

3.0 Nanomedicine Technology and Application Analysis

• 3.1 Nanomedicine Indication Analysis
  • 3.1.1 Clinical Oncology
  • 3.1.2 Infectious Diseases
  • 3.1.3 Cardiovascular Diseases
  • 3.1.4 Orthopaedic Diseases
  • 3.1.5 Neurological Diseases
  • 3.1.6 Urological Diseases
  • 3.1.7 Ophthalmological Diseases
  • 3.1.8 Immunological Diseases
• 3.2 Nanomedicine Application Analysis
  • 3.2.1 Drug Delivery
  • 3.2.2 Therapeutics
  • 3.2.3 Diagnostic Imaging (In-Vitro & In-Vivo)
  • 3.2.4 Anti-inflammatories
  • 3.2.5 Anti-invectives & Vaccines
  • 3.2.6 Regenerative Medicine
  • 3.2.7 Implants
• 3.3 Nanomedicine Molecule Analysis
  • 3.3.1 Nanoparticles
    • 3.3.1.1 Metal & Metal Oxide Nanoparticles
    • 3.3.1.2 Liposomes
    • 3.3.1.3 Polymers & Polymer Drug Conjugates
    • 3.3.1.4 Hydrogel Nanoparticles
    • 3.3.1.5 Dendrimers
    • 3.3.1.6 Inorganic Nanoparticles
  • 3.3.2 Nanoshells
  • 3.3.3 Nanotubes
  • 3.3.4 Nanodevices
• 3.4 Regional Adoption of Nanomedicine

4.0 Nanorobotics

• 4.1 Nanorobotics Solutions and Applications
• 4.2 The Commercial Environment for Nanorobotics

5.0 Nanomedicine Company Analysis

• 5.1 Abbott Laboratories
• 5.2 Arrowhead Pharmaceuticals Inc.
• 5.3 Celgene Corporation (Bristol Myers Squibb)
• 5.4 DiaSorin S.p.A.
• 5.5 GE Healthcare
• 5.6 Gilead Sciences Inc.
• 5.7 Invitae Corporation (CombiMatrix)
• 5.8 Johnson & Johnson Services Inc.
• 5.9 Leadient BioSciences Inc.
• 5.10 Thermo Fisher Scientific Inc. (Life Technologies)
• 5.11 Luminex Corporation (DiaSorin Company)
• 5.12 MagArray Inc.
• 5.13 Mallinckrodt Pharmaceuticals
• 5.14 Merck & Co. Inc.
• 5.15 Nanospectra Biosciences
• 5.16 Novsvax
• 5.17 Pfizer Inc.
• 5.18 Sanofi SA
• 5.19 Teva Pharmaceutical Industries Ltd
• 5.20 UCB S.A.

6.0 Nanomedicine Market Analysis and Forecasts 2026 – 2030

• 6.1 Global Nanomedicine Market 2026 – 2030
  • 6.1.1 Global Nanomedicine Market by Modality
  • 6.1.2 Global Nanomedicine Market by Application
  • 6.1.3 Global Nanomedicine Market by Indication
  • 6.1.4 Global Nanomedicine Market by Molecule Type
    • 6.1.4.1 Global Nanomedicine Molecule Market by Nanoparticles Type
  • 6.1.5 Global Nanomedicine Market by Region
    • 6.1.5.1 North America Nanomedicine Market by Country
    • 6.1.5.2 Europe Nanomedicine Market by Country
    • 6.1.5.3 APAC Nanomedicine Market by Country
    • 6.1.5.4 MEA Nanomedicine Market by Country
    • 6.1.5.5 Latin America Nanomedicine Market by Country
• 6.2 Regional Nanomedicine Market 2026 – 2030
  • 6.2.1 North America Nanomedicine Market: Application, Indication and Molecule
  • 6.2.2 Europe Nanomedicine Market: Application, Indication, and Molecule
  • 6.2.3 APAC Nanomedicine Market: Application, Indication, and Molecule
  • 6.2.4 MEA Nanomedicine Market: Application, Indication, and Molecule
  • 6.2.5 Latin America Nanomedicine Market: Application, Indication, and Molecule
• 6.3 Additional Nanomedicine Market Factors to Consider

7.0 Conclusions and Recommendations